Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and efficacy of avelumab plus carboplatin in patients with metastatic castration-resistant prostate cancer in an open-label Phase Ib study.
Rodriguez-Vida A, Maroto P, Font A, Martin C, Mellado B, Corbera A, Orrillo M, Reig O, Querol R, Rios-Hoyo A, Cano L, Alonso J, Martinez G, Galtes S, Taus A, Martinez-Garcia M, Juanpere N, Juan O, Bellmunt J. Rodriguez-Vida A, et al. Among authors: juanpere n. Br J Cancer. 2023 Jan;128(1):21-29. doi: 10.1038/s41416-022-01991-4. Epub 2022 Oct 26. Br J Cancer. 2023. PMID: 36289372 Free PMC article. Clinical Trial.
FGFR3 mutations in prostate cancer: association with low-grade tumors.
Hernández S, de Muga S, Agell L, Juanpere N, Esgueva R, Lorente JA, Mojal S, Serrano S, Lloreta J. Hernández S, et al. Among authors: juanpere n. Mod Pathol. 2009 Jun;22(6):848-56. doi: 10.1038/modpathol.2009.46. Epub 2009 Apr 17. Mod Pathol. 2009. PMID: 19377444 Free article.
Strong cytoplasmic ETV1 expression has a negative impact on prostate cancer outcome.
Segalés L, Juanpere N, Lorenzo M, Albero-González R, Fumadó L, Cecchini L, Bellmunt J, Lloreta-Trull J, Hernández-Llodrà S. Segalés L, et al. Among authors: juanpere n. Virchows Arch. 2019 Oct;475(4):457-466. doi: 10.1007/s00428-019-02573-1. Epub 2019 Apr 23. Virchows Arch. 2019. PMID: 31016435
Genomic Predictors of Good Outcome, Recurrence, or Progression in High-Grade T1 Non-Muscle-Invasive Bladder Cancer.
Bellmunt J, Kim J, Reardon B, Perera-Bel J, Orsola A, Rodriguez-Vida A, Wankowicz SA, Bowden M, Barletta JA, Morote J, de Torres I, Juanpere N, Lloreta-Trull J, Hernandez S, Mouw KW, Taplin ME, Cejas P, Long HW, Van Allen EM, Getz G, Kwiatkowski DJ. Bellmunt J, et al. Among authors: juanpere n. Cancer Res. 2020 Oct 15;80(20):4476-4486. doi: 10.1158/0008-5472.CAN-20-0977. Epub 2020 Aug 31. Cancer Res. 2020. PMID: 32868381 Free PMC article.
SPOP and CHD1 alterations in prostate cancer: Relationship with PTEN loss, tumor grade, perineural infiltration, and PSA recurrence.
Hernández-Llodrà S, Segalés L, Juanpere N, Marta Lorenzo T, Salido M, Nonell L, David López T, Rodríguez-Vida A, Bellmunt J, Fumadó L, Cecchini L, Lloreta-Trull J. Hernández-Llodrà S, et al. Among authors: juanpere n. Prostate. 2021 Dec;81(16):1267-1277. doi: 10.1002/pros.24218. Epub 2021 Sep 17. Prostate. 2021. PMID: 34533858
Immunohistochemical markers as predictors of prognosis in multifocal prostate cancer.
Segalés L, Juanpere N, Gallarín N, Lorenzo M, López D, Perera-Bel J, Rodriguez-Vida A, Fumadó L, Cecchini L, Bellmunt J, Lloreta-Trull J, Hernández-Llodrà S. Segalés L, et al. Among authors: juanpere n. Virchows Arch. 2023 Nov 28. doi: 10.1007/s00428-023-03699-z. Online ahead of print. Virchows Arch. 2023. PMID: 38017230
44 results